abs423.txt	purpose		the	incidence	of	localized	prostate	cancer	has	decreased	with	shifts	inprostate	screening	while	recent	population	based	studies	demonstrated	astable	locoregional	they	categorized	organconfined	extraprostatic	and	lymph	node	positive	disease	together	however	toour	knowledge	contemporary	pelvic	lymphnode	metastases	remains	unknown	materials	methods	we	used	seer	(surveillance	epidemiology	end	results)data	from	2004	to	2014	identify	men	diagnosed	weanalyzed	trends	in	age	standardized	by	stage	theimpact	extent	on	mortality	was	assessed	adjusted	cox	proportionalhazard	analysis	results	during	study	period	annual	nonmetastatic	prostatecancer	5	119	1	2	931	9	per	million	(ir	0	57	95%	ci0	56-0	58	p	<0	01)	increasedfrom	54	79	47	ci	33-1	62	theincidence	distant	75	years	old	or	older	reached	a	nadir	in2011	compared	81	74-0	90	it	increased	in2012	2011	13	02-1	24	05)	risk	cancerspecific	significantly	(hr	4	2-4	(hr21	21	2-22	7	conclusions	is	increasingcoincident	decline	detection	whether	thisportends	an	increase	burden	advanced	simply	reflectsdecreased	lead	time	unclear	this	should	be	monitored	closely	asthe	n1	reflects	incurable	atdiagnosis
